{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T20:01:57Z","timestamp":1776801717697,"version":"3.51.2"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.breast.2023.103585","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T08:48:33Z","timestamp":1696236513000},"page":"103585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer"],"prefix":"10.1016","volume":"72","author":[{"given":"Anbok","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taewoo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su Hwan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woosung","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Chul","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Yul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeong-yoon","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihyoun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Do","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun-Ah","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil Soo","family":"Son","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se Jeong","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Sung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk-Jai","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Min","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youngbum","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhae","family":"Um","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hyuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beom Seok","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Ho","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suok Hyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Seung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkyun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Je-Ryong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han Shin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol Wan","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.breast.2023.103585_bib1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.4048\/jbc.2020.23.e52","article-title":"Clinical impact of primary prophylactic pegfilgrastim in breast cancer patients receiving adjuvant docetaxel-doxorubicin-cyclophosphamide chemotherapy","volume":"23","author":"Jeon","year":"2020","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.breast.2023.103585_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.breast.2021.01.005","article-title":"Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study","volume":"56","author":"Takashi","year":"2021","journal-title":"Breast"},{"key":"10.1016\/j.breast.2023.103585_bib3","first-page":"547","article-title":"Granulocyte colony-stimulating factors as prophylaxis against febrile neutropenia","volume":"23","author":"Miguel","year":"2015","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.breast.2023.103585_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.4174\/astr.2018.94.5.223","article-title":"Pegfilgrastim for primary prophylaxis of febrile neutropenia in breast cancer patients undergoing TAC chemotherapy","volume":"94","author":"Lee","year":"2018","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/j.breast.2023.103585_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jval.2010.10.037","article-title":"Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom","volume":"14","author":"Whyte","year":"2011","journal-title":"Value Health"},{"key":"10.1016\/j.breast.2023.103585_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S1548-5315(11)70766-5","article-title":"Costs of human resources in delivering cancer chemotherapy and managing chemotherapy-induced neutropenia in community practice","volume":"1","author":"Fortner","year":"2004","journal-title":"Commn Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib7","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1002\/cncr.21847","article-title":"Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients","volume":"106","author":"Kunderer","year":"2006","journal-title":"Cancer"},{"issue":"suppl 5","key":"10.1016\/j.breast.2023.103585_bib8","doi-asserted-by":"crossref","first-page":"v111","DOI":"10.1093\/annonc\/mdw325","article-title":"Management of febrile neutropaenia: ESMO clinical practice guidelines","volume":"27","author":"Klastersky","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib9","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1200\/JCO.2006.06.4451","article-title":"Update of Recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline","volume":"24","author":"Smith","year":"2006","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.breast.2023.103585_bib10","first-page":"S240","volume":"63","author":"Hawer","year":"2011","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.breast.2023.103585_bib11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3947\/ic.2011.43.4.285","article-title":"Evidence-based guidelines for empirical therapy of neutropenic fever in Korea","volume":"43","author":"Lee","year":"2011","journal-title":"Infect Chemother"},{"key":"10.1016\/j.breast.2023.103585_bib12","doi-asserted-by":"crossref","first-page":"328","DOI":"10.7326\/0003-4819-64-2-328","article-title":"Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia","volume":"64","author":"Bodey","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.breast.2023.103585_bib13","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/1097-0142(197804)41:4<1610::AID-CNCR2820410452>3.0.CO;2-B","article-title":"Fever and Infection in leukemic patients: a study of 494 consecutive patients","volume":"41","author":"Bodey","year":"1978","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.breast.2023.103585_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231828","article-title":"Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma","volume":"15","author":"Kirino","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.breast.2023.103585_bib15","first-page":"1137","article-title":"Phase III placebo-controlled, double-blind, randomized trial of Pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving Docetaxel\/Cyclophosphamide chemotherapy","volume":"23","author":"Yoshimasa","year":"2015","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.breast.2023.103585_bib16","doi-asserted-by":"crossref","first-page":"e1233","DOI":"10.1634\/theoncologist.2020-0105","article-title":"Eflapegrastim, a long-acting granulocyte-colony stimulating factor for the management of chemotherapy-induced neutropenia: results of a phase III rrial","volume":"25","author":"Lee","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib17","article-title":"Biosimilar versus originator pegfilgrastim for preventing chemotherapy-induced neutropenia: a phase III randomized, multicenter, evaluator-blinded","volume":"8","author":"Ruben","year":"2022","journal-title":"noninferiority study JCO Global Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00063030-200923030-00004","article-title":"Use of filgrastim and pegfilgrastim to support delivery of chemotherapy","volume":"23","author":"Renwick","year":"2009","journal-title":"BioDrugs"},{"issue":"6","key":"10.1016\/j.breast.2023.103585_bib19","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1200\/JCO.2005.09.102","article-title":"First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase \u2162 study","volume":"23","author":"Vogel","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib20","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1200\/JCO.2002.20.3.727","article-title":"Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage\u2161 or stage\u2162\/\u2163 breast cancer","volume":"20","author":"Holmes","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00001813-200304000-00002","article-title":"Pegfilgrastim: using pegylation technology to improve neutropenia support in cancer patients","volume":"14","author":"Molineux","year":"2003","journal-title":"Anti Cancer Drugs"},{"key":"10.1016\/j.breast.2023.103585_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s12032-015-0537-7","article-title":"An open-label, ranbdomized, multicenter dose-finding study of once-per-cycle pegfilgrastim versus daily filgrastim in Chinese breast cancer patients receiving TAC chemotherapy","volume":"32","author":"Zhang","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.breast.2023.103585_bib23","doi-asserted-by":"crossref","first-page":"e746","DOI":"10.1634\/theoncologist.2019-0647","article-title":"Real-world evidence in oncology: opportunities and limitations","volume":"25","author":"Massimo","year":"2020","journal-title":"Oncol"},{"issue":"9","key":"10.1016\/j.breast.2023.103585_bib24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/1060028017706373","article-title":"Pegfilgrastim-induced bone pain: a review on incidence, risk factors, and evidence-based management","volume":"41","author":"Moore","year":"2017","journal-title":"Ann Pharmacother"},{"issue":"51","key":"10.1016\/j.breast.2023.103585_bib25","article-title":"Long-acting versus short-acting granulocyte colony-stimulating factors among cancer patients after chemotherapy in China: a systematic review and meta-analysis of randomized controlled trials","volume":"100","author":"Genzhu","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.breast.2023.103585_bib26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3390\/biology11020340","article-title":"Comparative study of adverse drug reactions associated with filgrastim and pegfilgrastim using the EudraVigilance Databace. S Rastogi, V Kalaiselvan, et al","volume":"11","author":"Rastogi","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.breast.2023.103585_bib27","unstructured":"NEULASTA\u00ae (pegfilgrastim) injection, for subcutaneous use, FDA Label."},{"key":"10.1016\/j.breast.2023.103585_bib28","article-title":"The effect of reduced RDI of chemotherapy on the outcome of breast cancer patients","volume":"10","author":"Wanwan","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.breast.2023.103585_bib29","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1200\/JCO.2006.08.8823","article-title":"Impact of primary prophylaxis with granulocyte colony stimulating factor on febrile neutropenia and mortality in adult cancer patients receiving chemotherapy: a systematic review","volume":"25","author":"Nicole","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623005611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977623005611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:47:14Z","timestamp":1760777234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977623005611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"alternative-id":["S0960977623005611"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2023.103585","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2023.103585","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103585"}}